What Vastrax does

Vastrax, Inc. is a global full-service Contract Research Organization (CRO) exclusively dedicated to supporting the clinical development of neurological therapies. Founded in 2016 and headquartered in Waltham, Massachusetts, the company serves pharmaceutical sponsors, biotechnology companies, and neuro device startups running trials across stroke (ischemic, hemorrhagic, neuroprotective), aneurysm (flow-diversion and embolic devices), neuro-pharma, brain-computer interface, AI-powered diagnostic imaging, neuromodulation, robotics, spine, and micro-access tools. Its core service portfolio spans trial operations, regulatory expertise (US and EU), study design, clinical monitoring, biometrics, elite site partnerships, safety, and consulting — offered either as end-to-end program management or as targeted gap-fill support.

The company operates as a professional services firm rather than a technology product company; its differentiated capability rests on a team of 50+ seasoned clinical research professionals averaging 15+ years of experience who have collectively supported 125+ neuro programs including landmark studies and multiple product approvals. AI is used narrowly within biometrics to surface program trend insights across large multinational trials. Revenue is generated through negotiated, quote-based B2B contracts with sponsors, with no public pricing disclosed; the go-to-market is enterprise field sales driven by therapeutic-area credibility, KOL and elite investigator relationships, and a validated regulatory posture that includes successful FDA audits at both organizational and study-site levels.

Vastrax is privately held with no disclosed parent company, institutional investors, or venture funding in the available source material, and no current job openings are listed on its careers page. Ownership, leadership team details beyond the founder/president, and any quantitative financial metrics (revenue, headcount time-series, contract values) are not evidenced in the input data, limiting external triangulation of scale and growth.

Name

Vastrax

Legal name

Vastrax, Inc.

Website

https://vastrax.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Vastrax is a global full-service CRO exclusively focused on neurological therapies, serving pharma sponsors, biotechs, and neuro device startups with trial operations, regulatory, biometrics, and elite site network services across stroke, aneurysm, BCI, AI-imaging, and neuromodulation programs.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Contract Research Organization)

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Clinical research services
• Neurology CRO
• Neurovascular trials
• Biometrics analysis
• Regulatory affairs

Headquarters

HQ city

Andover

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel

Revenue model

1. CRO Services - Professional Services: Vastrax provides comprehensive global CRO services including trial operations, regulatory expertise, study design, clinical monitoring, biometrics, site partnerships, and safety services. Revenue is generated through professional services contracts with pharmaceutical sponsors, biotech companies, and neuro device startups. Services are tailored to client needs from end-to-end study management to filling targeted gaps.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Vastrax is a global full-service Contract Research Organization (CRO) exclusively supporting the development of neurological therapies. It delivers a comprehensive suite of integrated services—Trial Operations, Regulatory Expertise, Study Design, Clinical Monitoring, Biometrics, Elite Site Partnerships, and Safety Services—to pharmaceutical sponsors, biotech companies, and neuro device startups across stroke, aneurysm, AI-imaging, brain-computer interface, neuromodulation, spine, and neuro-pharma programs.

Product overview

Vastrax is a global full-service Contract Research Organization (CRO) exclusively focused on neurological therapies. The company offers a comprehensive suite of integrated services including Trial Operations, Regulatory Expertise, Study Design, Clinical Monitoring, Biometrics (with AI-enabled insights), Elite Site Partnerships, and Safety Services. Their service portfolio is organized around core functional areas that work together across the clinical development lifecycle. Vastrax specializes in multiple neuro indication areas: Stroke (ischemic, hemorrhagic, neuroprotective), Aneurysm (flow-diversion and embolic devices), Neuro-Pharma (small-molecule, biologic, gene-based treatments), Brain-Computer Interface (BCI/BMI), Imaging/AI, Neuromodulation, robotics, spine, and micro-access tools. The company combines the scale of a global organization with boutique partner agility to deliver faster activations and cleaner data for neurological clinical programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Trial Operations Oversees all program phases with clear timelines and consistent communication for pharmaceutical sponsors, biotech companies, and neuro device startups running neurological clinical trials.
• Regulatory Expertise Provides extensive US and EU regulatory experience, guiding clinical sponsors through regulatory interactions with proactive planning to position programs for success.
• Study Design Provides comprehensive design input including protocol refinement and endpoint selection that reduces risk and positions neurological trials for faster approvals.
• Clinical Monitoring Global clinical monitoring team averaging 15+ years of experience, ensuring quality data through consistent oversight across neurological trial sites.
• Biometrics Designs efficient analysis plans and proactively manages complex datasets with speed, transparency, and accuracy, integrating AI-enabled insights to surface program trends in large multinational neurological studies.
• Elite Site Partnerships Provides clinical sponsors access to elite investigators and veteran coordinators at established global sites to keep neurological trials on track with quality data.
• Safety Services Safeguards subject well-being and ensures regulatory compliance and data integrity across neurological clinical programs.
• Consulting & Study Design Brings decades of neurovascular trial experience to assist sponsors in refining protocols, selecting endpoints, and preparing regulatory packages for neurological therapies.

Named customers3 records

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Clinipace Worldwide: Mid-sized digital CRO focused on emerging and mid-market biotech and device sponsors. Overlaps with Vastrax in therapeutic-area expertise-driven service model and BCI/neuro device startup customer profile.

Direct peers

• Precision for Medicine: Specialty CRO focused on biotech and device sponsors with strong CNS and rare disease capabilities. Closely comparable in therapeutic-area specialization and customer profile to Vastrax.
• CTI Clinical Trial and Consulting Services: Specialty CRO with deep expertise in neuroscience, rare disease, and complex clinical programs. Competes with Vastrax for neuro-focused study design, regulatory strategy, and global trial execution.
• Premier Research: Specialty CRO with deep expertise in neurology, rare disease, and medical device trials. Competes head-to-head with Vastrax for neuro-focused study design, regulatory navigation, and global clinical monitoring work.
• Veristat: Specialty clinical and biometrics CRO serving small and mid-sized biotech and device sponsors with complex trial designs. Comparable to Vastrax in serving niche, expertise-intensive neuro programs with high-touch engagement.
• Worldwide Clinical Trials: Mid-sized global CRO with a well-established neuroscience franchise spanning CNS trials and rare neurological disease. Direct competitor for Vastrax in neuro-focused clinical operations, biometrics, and regulatory services to pharma and device sponsors.

Broad incumbents

• ICON plc: Global full-service CRO with significant CNS and neuro device exposure via the PRA Health Sciences combination. Competes for large neuro trials where scale, geographic reach, and integrated technology platforms matter.
• IQVIA: Largest global CRO with broad neuroscience practice and dedicated neuro operations. Competes with Vastrax on enterprise neuro trials but offers materially deeper resourcing and a broader therapeutic portfolio.
• Parexel: Large global CRO with established neurology practice and strong medical device trial capabilities. Overlaps with Vastrax in neurovascular device and neuro-pharma trial execution but at significantly larger scale.
• Medpace: Mid-to-large full-service CRO with growing neuroscience and neuro device capabilities and a global operating footprint. Competes with Vastrax on full-service neuro trials but at meaningfully greater scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vastrax

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vastrax